Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
AAV2-shControl
- Development stage
- Preclinical
- Modality
- Viral-delivered RNAi → In Vivo RNAi → Gene Silencing → Gene Therapies, Viral Vectors → Gene Addition/Replacement → Gene Therapies, Gene Editing → Gene Therapies
- Administration
- Intracerebral, Intravitreal, Intravenous
01
Overview
AAV2-shControl is an experimental gene therapy reagent utilizing an adeno-associated virus serotype 2 (AAV2) vector to deliver a control short hairpin RNA (shRNA) sequence. The term "shControl" indicates that the construct does not target a specific gene, and is used as a negative control in studies evaluating RNA interference-based gene therapy. The AAV2 vector is widely used in gene therapy due to its neuronal tropism and low immunogenicity. AAV2-shControl serves as a control arm in experimental settings for comparison with therapeutic AAV2-shRNA constructs targeting specific genes. Its primary application is in preclinical and early-stage research to validate safety, specificity, and non-target effects of AAV2-mediated RNA interference methodologies.
- Other names
- AAV2-shControlAAV-2-shControlAAV 2-shControl
02
Targets
αVβ5 (Integrin αVβ5)ITGA5:ITGB1 (Integrin α5β1)FGFR1 (Fibroblast growth factor receptor 1)HSPG (Basement membrane-specific heparan sulfate proteoglycan core protein (perlecan))
Beyond the preview
Go deeper on AAV2-shControl.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on AAV2-shControl.